No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /

No. 201 - 300 Paclitaxel Patents:

	PAT. NO		Title
201	6,419,709		Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same
202	6,417,394		Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators
203	6,417,335		Protein purification
204	6,417,176		Arylsulfonanilide phosphates
205	6,417,160		Methods for increasing schwann cell survival
206	6,416,959		System for cell-based screening
207	6,416,758		Antibody conjugate kits for selectively inhibiting VEGF
208	6,414,015		Laulimalide microtubule stabilizing agents
209	6,414,014		Method for administration of taxol
210	6,413,964		Inhibitors of prenyl-protein transferase
211	6,413,957		Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones
212	6,413,770		NL4 tie ligand homologue nucleic acid
213	6,413,755		Human checkpoint kinase, HCDS1, compositions and methods
214	6,413,536		High viscosity liquid controlled delivery system and medical or surgical device
215	6,413,507		Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
216	6,410,802		Methods for synthesizing ether compounds and intermediates therefor
217	6,410,757		Baccatin derivatives and a process for producing the same
218	6,410,756		Family of Canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
219	6,410,708		Nucleic acids encoding A-33 related antigen polypeptides
220	6,410,687		Polypeptides for the detection of microtubule depolymerization inhibitors
221	6,410,534		Inhibitors of prenyl-protein transferase
222	6,410,301		Myxococcus host cells for the production of epothilones
223	6,410,059		Pharmaceutical composition containing cow urine distillate and an antibiotic
224	6,409,750		Woven bifurcated and trifurcated stents and methods for making the same
225	6,407,244		Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
226	6,407,131		Compounds and method for use thereof in the treatment of cancer or viral infections
227	6,407,124		Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
228	6,407,117		Method of administering camptothecin compounds for the treatment of cancer with reduced side effects
229	6,407,105		Compounds and methods for use thereof in the treatment of cancer or viral infections
230	6,407,103		Indeno [1,2-c] pyrazol-4-ones and their uses
231	6,406,867		Antibody to human endokine alpha and methods of use
232	6,406,722		Method of treating viral infections and lesions with taxane compounds
233	6,406,693		Cancer treatment methods using antibodies to aminophospholipids
234	6,403,770		Antibodies to neutrokine-alpha
235	6,403,758		Bioresorbable compositions for implantable prostheses
236	6,403,675		Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
237	6,403,630		Treating cancers associated with overexpression of HER-2/neu
238	6,399,783		Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
239	6,399,638		12,13-modified epothilone derivatives
240	6,399,606		Neuroprotective agents and methods related thereto
241	6,395,771		Paclitaxel derivatives for the treatment of cancer
242	6,395,770		Method and compositions for administering taxanes orally to human patients
243	6,395,749		Carboxamide compounds, methods, and compositions for inhibiting PARP activity
244	6,395,734		Pyrrole substituted 2-indolinone protein kinase inhibitors
245	6,395,718		Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
246	6,395,712		Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
247	6,395,506		Device for monitoring cells
248	6,395,326		Apparatus and method for depositing a coating onto a surface of a prosthesis
249	6,395,300		Porous drug matrices and methods of manufacture thereof
250	6,395,266		Terminally-branched polymeric linkers and polymeric conjugates containing the same

251	6,392,063		Hydrolysis-promoting hydrophobic taxane derivatives
252	6,392,055		Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin A
253	6,391,913		Derivatives of paclitaxel, method for producing same and uses thereof
254	6,391,895		Nitric oxide releasing chelating agents and their therapeutic use
255	6,391,893		Pyridine compounds use and preparation thereof
256	6,391,884		Withdrawn
257	6,391,832		Medical emulsion for lubrication and delivery of drugs
258	6,391,589		Human chemokine beta-10 mutant polypeptides
259	6,391,343		Fibrinogen-coated particles for therapeutic use
260	6,388,131		Benzene compounds as antiproliferative and cholesterol lowering agents
261	6,388,112		Process for purification of solvents useful in the preparation of pharmaceutical compositions
262	6,387,946		Methods for treating pathological conditions of abnormal cell proliferation
263	6,387,923		Imminoribitol PNP inhibitors, preparation thereof and use thereof
264	6,387,903		Inhibitors of prenyl-protein transferase
265	6,387,902		Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
266	6,387,657		WISP polypeptides and nucleic acids encoding same
267	6,387,406		Copolymer compositions for oral delivery
268	6,384,187		Antiproliferative activity of microsclerodermins
269	6,384,049		Cancer treatment
270	6,384,022		Prodrugs of NAALAdase inhibitors
271	6,383,808		Antisense inhibition of clusterin expression
272	6,383,789		Isolated human UDP-glycosyltransferase, nucleic acid molecules encoding human UDP-glycosyltransferase, and uses thereof
273	6,383,522		Toxicity reduced composition containing an anti-neoplastic agent and a shark cartilage extract
274	6,383,509		Biodegradable neurotoxin implant
275	6,380,405		Taxane prodrugs
276	6,380,395		12, 13-cyclopropane epothilone derivatives
277	6,380,394		Epothilone analogs
278	6,380,232		Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
279	6,380,228		Inhibitors of prenyl-protein transferase
280	6,380,227		Fermentative preparation process for and crystal forms of cytostatics
281	6,380,211		Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
282	6,380,193		Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
283	6,380,167		Methods for anti-tumor therapy
284	6,380,161		Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions
285	6,379,382		Stent having cover with drug delivery capability
286	6,379,381		Porous prosthesis and a method of depositing substances into the pores
287	6,379,379		Stent with smooth ends
288	6,376,649		Methods for the synthesis of .alpha.- hydroxy-.beta.-amino acid and amide derivatives
289	6,376,644		Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same
290	6,376,604		Method for the preparation of 1-benzotriazolylcarbonate esters of poly(ethylene glycol)
291	6,376,525		Method and composition for treating cancer using cellular organelle crystallizing agents
292	6,376,518		Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
293	6,376,514		Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
294	6,376,496		Inhibitors of prenyl-protein transferase
295	6,376,470		Polymer conjugates of ara-C and ara-C derivatives
296	6,376,224		Pharmaceutical compositions for eliminating membrane-mediated cell resistance
297	6,375,956		Strip pack
298	6,372,922		Process for the production of (-) 3,4-divanillyl tetrahydrofuran
299	6,372,780		Methods of treating cell lines expressing multidrug resistance P-glycoprotein
300	6,372,775		Reversal of multidrug resistance in human colon carcinoma cells

No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /